A Phase I/II Study to Assess the Safety and Therapeutic Effect of INCB007839 in Combination With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 06 Oct 2011
At a glance
- Drugs Aderbasib; Trastuzumab; Vinorelbine
- Indications Advanced breast cancer
- Focus Adverse reactions
- 06 Oct 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 Dec 2010 New trial record